Literature DB >> 10439038

Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.

G Handschuh1, S Candidus, B Luber, U Reich, C Schott, S Oswald, H Becke, P Hutzler, W Birchmeier, H Höfler, K F Becker.   

Abstract

A major function of the cell-to-cell adhesion molecule E-cadherin is the maintenance of cell adhesion and tissue integrity. E-cadherin deficiency in tumours leads to changes in cell morphology and motility, so that E-cadherin is considered to be a suppressor of invasion. In this study we investigated the functional consequences of three tumour-associated gene mutations that affect the extracellular portion of E-cadherin: in-frame deletions of exons 8 or 9 and a point mutation in exon 8, as they were found in human gastric carcinomas. Human MDA-MB-435S breast carcinoma cells and mouse L fibroblasts were stably transfected with the wild-type and mutant cDNAs, and the resulting changes in localization of E-cadherin, cell morphology, strength of calcium-dependent aggregation as well as cell motility and actin cytoskeleton organization were studied. We found that cells transfected with wild-type E-cadherin showed an epitheloid morphology, while all cell lines expressing mutant E-cadherin exhibited more irregular cell shapes. Cells expressing E-cadherin mutated in exon 8 showed the most scattered appearance, whereas cells with deletion of exon 9 had an intermediate state. Mutant E-cadherins were localized to the lateral regions of cell-to-cell contact sites. Additionally, both exon 8-mutated E-cadherins showed apical and perinuclear localization, and actin filaments were drastically reduced. MDA-MB-435S cells with initial calcium-dependent cell aggregation exhibited decreased aggregation and, remarkably, increased cell motility, when mutant E-cadherin was expressed. Therefore, we conclude that these E-cadherin mutations may not simply affect cell adhesion but may act in a trans-dominant-active manner, i.e. lead to increased cell motility. Our study suggests that E-cadherin mutations affecting exons 8 or 9 are the cause of multiple morphological and functional disorders and could induce the scattered morphology and the invasive behaviour of diffuse type-gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439038     DOI: 10.1038/sj.onc.1202790

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  E- and N-cadherin distribution in developing and functional human teeth under normal and pathological conditions.

Authors:  Robert Heymann; Imad About; Urban Lendahl; Jean-Claude Franquin; Björn Obrink; Thimios A Mitsiadis
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

2.  Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer.

Authors:  Tatsuhiro Shibata; Akiko Kokubu; Shigeki Sekine; Yae Kanai; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

3.  X-interface is not the explanation for the slow disassembly of N-cadherin dimers in the apo state.

Authors:  Nagamani Vunnam; Susan Pedigo
Journal:  Protein Sci       Date:  2012-05-24       Impact factor: 6.725

4.  Cadherin point mutations alter cell sorting and modulate GTPase signaling.

Authors:  Hamid Tabdili; Adrienne K Barry; Matthew D Langer; Yuan-Hung Chien; Quanming Shi; Keng Jin Lee; Shaoying Lu; Deborah E Leckband
Journal:  J Cell Sci       Date:  2012-04-14       Impact factor: 5.285

5.  Allosteric cross talk between cadherin extracellular domains.

Authors:  Quanming Shi; Venkat Maruthamuthu; Fang Li; Deborah Leckband
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

6.  Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.

Authors:  K F Becker; E Kremmer; M Eulitz; I Becker; G Handschuh; C Schuhmacher; W Müller; H E Gabbert; A Ochiai; S Hirohashi; H Höfler
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

8.  Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.

Authors:  Hyuk-Joon Lee; Hye Seung Lee; Keun Hur; Woo Ho Kim; Kazuyoshi Yanagihara; Karl-Friedrich Becker; Kuhn Uk Lee; Han-Kwang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-19       Impact factor: 4.553

9.  Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.

Authors:  Masatoshi Kakihana; Tatsuo Ohira; Daniel Chan; Robin B Webster; Harubumi Kato; Harry A Drabkin; Robert M Gemmill
Journal:  J Thorac Oncol       Date:  2009-12       Impact factor: 15.609

Review 10.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.